Skip to main content

Table 1 Patient characteristics of the SALT cohort, S. aureus SSI cases, and controls

From: Staphylococcus aureus surgical site infection rates in 5 European countries

Characteristic

Cohort

S. aureus SSI cases

Controls

p-value (SSI cases vs. controls)

Age

Mean

56.7

58.1 (18–95)

57.7 (18–97)

p = 0.704

Age groups [% (n)]

18–29

9.5 (17,056)

9.5 (71)

11.4 (85)

 

30–44

19.0 (33,967)

16.7 (124)

17.1 (127)

 

45–59

23.3 (41,728)

20.4 (152)

19.6 (146)

 

60–75

30.2 (53,981)

34.3 (255)

30.9 (230)

 

 > 75

17.98 (32,170)

19.1 (142)

21.0 (156)

 

Sex [% (n)]

   

p = 0.604

Female

51.7 (92,468)

48.1 (358)

46.6 (347)

 

Male

48.3 (86,434)

51.9 (386)

53.4 (397)

 

BMI [% (n)]*

n/a

  

p = 0.767

 < 18.5

 

1.9 (12)

2.2 (13)

 

18.5–24.9

32.3 (204)

 

44.4 (263)

 

25.0–29.9

 

34.4 (215)

32.5 (193)

 

30.0–34.9

 

20.8 (130)

15.3 (91)

 

35.0–39.9

 

6.9 (43)

4.0 (24)

 

 > 40

 

3.4 (21)

1.5 (9)

 

Comorbidities Cardiovascular

Chronic CVD

4.39 (4454/101410)

23.1 (172)

21.9 (163)

p = 0.620

Congestive HF

1.07 (1082/101410)

7.7 (57)

5.5 (41)

p = 0.117

Peripheral VD

3.43 (3482/101410)

12.1 (90)**

8.1 (60)**

p = 0.012

Pulmonal

COPD

1.45 (1475/101410)

6.2 (46)

4.4 (33)

p = 0.165

Cancer

Leukemia

0.15 (154/101410)

0.4 (3)

0.3 (2)

p = 1.000

Lymphoma

0.28 (285/101410)

2.2 (16)

0.9 (7)

p = 0.091

Solid tumor

7.29 (7396/101410)

22.3 (166)**

15.6 (116)**

p = 0.001

Neurological

Dementia

0.32 (321/101410)

2.3 (17)

2.4 (18)

p = 1.000

TIA or CVA

0.13 (132/101410)

5.8 (43)

5.8 (43)

p = 0.591

Hemiplegia

0.89 (904/101410)

1.3 (10)**

3.1 (23)**

p = 0.033

Other Internal

Diabetes

11.43 (11,591/178904)

21.0 (156)

176 (131)

p = 0.115

Liver disease

1.12 (1138/101410)

4.4 (33)

5.0 (37)

p = 0.714

CKD

3.22 (3271/101410)

7.8 (58)

7.0 (52)

p = 0.620

Other

HIV/AIDS

0.09 (96/101410)

(9)

(6)

p = 0.605

  1. *For BMI calculation, only 625 cases were included due to missing data in the remaining cases
  2. **Statistically significant difference between S. aureus SSI cases and controls. For further details refer to Supp. Table 2
  3. AIDS Acquired immunodeficiency disease, CVA Cerebral vascular accident, CKD Chronic kidney disease, CVD Chronic cardiovascular diseases, HIV Human immunodeficiency virus, HF Heart failure, SA Staphylococcus aureus, SSI Surgical site infection, VD Vascular diseases, TIA Transient ischemic attack, CVA